periplasmic expression of tnf related apoptosis inducing ligand (trail) in e.coli
Authors
abstract
tumor necrosis factor-related apoptosis-inducing ligand (trail), a member of tnf family, is an interesting ligand which selectively induces apoptosis in tumor cells and, therefore, it has been developed for cancer therapy. this ligand has been produced by various hosts such as e.coli. however, protein expression in e.coli cytoplasm leads to problems such as incorrect folding, reduction in biological activity, inclusion body formation, and sophisticated downstream. the aim of this study is to develop an expression system for the production of recombinant trail secreted to the e.coli periplasm instead of cytoplasm. by using overlapping extension pcr, an ompa signal sequence was fused to trail cdna and ompa-trail fragment was then cloned in pet-22b plasmid. this construct was confirmed by pcr and dna sequencing. promoter was induced in e.coli bl21 (de3) and periplasmic expressed proteins were released using osmotic shock procedure. sds-page analysis showed that about 37% of recombinant trail was transferred into the periplasm and its identity was confirmed by western blot analysis. finally, the cytotoxic activity of trail against hela cell line was confirmed by using mtt assay. the results demonstrate that our expression system may be useful for the production of trail in the periplasmic space
similar resources
Periplasmic Expression of TNF Related Apoptosis Inducing Ligand (TRAIL) in E.coli
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of TNF family, is an interesting ligand which selectively induces apoptosis in tumor cells and, therefore, it has been developed for cancer therapy. This ligand has been produced by various hosts such as E.coli. However, protein expression in E.coli cytoplasm leads to problems such as incorrect folding, reduction in biolo...
full textPeriplasmic Expression of TNF Related Apoptosis Inducing Ligand (TRAIL) in E.coli
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of TNF family, is an interesting ligand which selectively induces apoptosis in tumor cells and, therefore, it has been developed for cancer therapy. This ligand has been produced by various hosts such as E.coli. However, protein expression in E.coli cytoplasm leads to problems such as incorrect folding, reduction in biolo...
full textPeriplasmic Expression of TNF Related Apoptosis Inducing Ligand (TRAIL) in E.coli
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of TNF family, is an interesting ligand which selectively induces apoptosis in tumor cells and, therefore, it has been developed for cancer therapy. This ligand has been produced by various hosts such as E.coli. However, protein expression in E.coli cytoplasm leads to problems such as incorrect folding, reduction in biolo...
full textCloning and Expression of TNF Related Apoptosis Inducing Ligand in Nicotiana tabacum
Molecular farming has been considered as a secure and economical approach for production of biopharmaceuticals. Human TNF Related Apoptosis Inducing Ligand (TRAIL) as a promising biopharmaceutical candidate has been produced in different expression hosts. However, little attention has been paid to molecular farming of the TRAIL in spite of numerous advantages of plant expression systems. Theref...
full textCloning and Expression of TNF Related Apoptosis Inducing Ligand in Nicotiana tabacum
Molecular farming has been considered as a secure and economical approach for production of biopharmaceuticals. Human TNF Related Apoptosis Inducing Ligand (TRAIL) as a promising biopharmaceutical candidate has been produced in different expression hosts. However, little attention has been paid to molecular farming of the TRAIL in spite of numerous advantages of plant expression systems. Theref...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of pharmaceutical researchجلد ۱۴، شماره ۲، صفحات ۶۱۷-۶۲۶
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023